SkinBioTherapeutics (LON:SBTX) Trading Down 0.1% – Here’s Why

SkinBioTherapeutics plc (LON:SBTX)’s share price fell 0.1% on Tuesday . The company traded as low as GBX 17.50 ($0.22) and last traded at GBX 17.73 ($0.22). 257,072 shares traded hands during trading, a decline of 42% from the average session volume of 439,623 shares. The stock had previously closed at GBX 17.75 ($0.22).

SkinBioTherapeutics Stock Down 0.1 %

The company has a quick ratio of 10.01, a current ratio of 6.57 and a debt-to-equity ratio of 2.66. The company has a market cap of £40.07 million, a PE ratio of -886.25 and a beta of 2.01. The company’s fifty day moving average is GBX 17.06 and its 200-day moving average is GBX 14.20.

SkinBioTherapeutics (LON:SBTX) last released its quarterly earnings results on Wednesday, December 4th. The company reported GBX (1.54) (($0.02)) earnings per share (EPS) for the quarter.

About SkinBioTherapeutics

SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.